E
bioAffinity Technologies, Inc. BIAF
$0.2872 -$0.0088-2.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -35.61% -25.02% 12.66% -21.27% -27.99%
Total Depreciation and Amortization 3.34% 3.23% 162.67% 599.54% 589.40%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 15.12% -0.17% -0.38% 68.06% 80.01%
Change in Net Operating Assets 165.74% 141.43% -108.83% -25.37% -365.81%
Cash from Operations 30.02% -3.77% -11.53% -12.68% -53.43%
Capital Expenditure -22.71% -100.00% -4,600.00% -625.64% -28.17%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -22.71% -100.00% 99.57% -625.64% -28.17%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -56.93% -7.31% -79.13% 28.31% -6.48%
Issuance of Common Stock -54.51% -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -48.89% 2,489.03% 3,395.08% 27.76% 2,523.77%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -79.32% 120.66% 98.81% -10.87% 77.60%